What it isThe primary active component of CBT-I, in which the patient temporarily limits time in bed to match their actual average sleep duration — creating sleep pressure that consolidates fragmented sleep into a continuous, restorative period. Once sleep efficiency improves, time in bed is gradually extended toward the target duration.

Why it mattersChronic insomnia is maintained partly by spending too much time in bed awake, which weakens the association between bed and sleep and reduces the sleep pressure needed for consolidated sleep onset. Sleep restriction therapy reverses this by rebuilding sleep pressure and reconditioning the bed-sleep association.

Think of it like thisSleep restriction therapy is like fasting before a meal to build a real appetite. Instead of eating when you’re not hungry, you wait until your body genuinely needs food — so the meal is fully satisfying and restorative.

A behavioral insomnia treatment in which the sleep window (time in bed) is prescribed to equal the patient’s current average actual sleep time, with a minimum floor of 5–6 hours. This produces mild sleep deprivation that increases homeostatic sleep pressure, reduces sleep onset latency, reduces wake after sleep onset, and improves sleep efficiency. Once sleep efficiency exceeds 85–90% for 5+ consecutive days, the window is extended by 15–30 minutes. The process continues until the target sleep duration is achieved.

MechanismBy restricting time in bed to near actual sleep time, sleep restriction rebuilds homeostatic sleep pressure (adenosine accumulation) and reduces conditioned wakefulness in the sleep environment. The resulting increase in sleep drive shortens sleep onset latency, reduces mid-night awakenings, and consolidates sleep architecture. It is the component of CBT-I most responsible for rapid symptomatic improvement, typically within 1–2 weeks.